Lv1
20 积分 2022-05-09 加入
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
5小时前
待确认
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
11小时前
已完结
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy
4天前
已关闭
N-803: a double-edged sword in haplo-NK therapy
8天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation
2个月前
已完结
Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins
3个月前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
6个月前
已完结
Event-Triggered Real-Time Scheduling of Stabilizing Control Tasks
6个月前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
7个月前
已完结
中国成年人生活方式和心血管代谢因素与甲基化年龄加速的相关性分析
2年前
已采纳
皮肤炎症性衰老与治疗策略
2年前
已采纳
皖公网安备34019202002308
